NPC radiation resistance may be enhanced via the PPAR coactivator-1α (PGC1α)/CCAAT/enhancer binding protein β (CEBPB)/CPT1A/FAO signaling axis (Du et al., 2019). The gene discussed is CPT1A; the disease is nasopharyngeal carcinoma.